Department of Urology, Fox Chase Cancer Center, Philadelphia, PA.
Department of Urology, University of California, Irvine, Orange, CA.
Urology. 2023 Nov;181:150-154. doi: 10.1016/j.urology.2023.06.037. Epub 2023 Sep 15.
To assess the difference in outcomes between single dilation (SingD) and sequential dilation (SeqD) in primary penile implantation, hypothesizing that patients who undergo SeqD had higher rates of noninfectious complications.
We performed a multicenter, retrospective study of men undergoing primary inflatable penile prosthesis placement. Intraoperative complications and postoperative noninfectious outcomes were assessed between the two groups. Multivariable analysis was performed to identify predictors of complications.
A total of 3293 patients met inclusion criteria. After matching, there were 379 patients who underwent SingD and 379 patients who underwent SeqD. There was no significant difference in intraoperative complications between patients who underwent SingD vs SeqD, nor was there any difference in cylinder length (20 cm with interquartile range [IQR] 18-21 cm vs 20 cm with IQR 18-20 cm respectively, P = .4). On multivariable analysis, SeqD (OR 5.23 with IQR 2.74-10, P < .001) and older age (OR 1.04 with IQR 1.01-1.06, P = .007) were predictive of postoperative noninfectious complications. There was no significant difference in intraoperative complications between patients who underwent SingD vs SeqD, nor was there any difference in cylinder length. SeqD and older age were predictive of postoperative noninfectious complications.
During inflatable penile prosthesis placement in the uncomplicated patient without fibrosis, SingD is a safe technique to utilize during implantation that will minimize postoperative adverse events, and promote device longevity without loss of cylinder length.
评估原发性阴茎植入中单次扩张(SingD)与序贯扩张(SeqD)在结果方面的差异,假设接受 SeqD 的患者发生非感染性并发症的比例更高。
我们对接受原发性可膨胀阴茎假体植入术的男性进行了一项多中心回顾性研究。在两组患者之间评估了术中并发症和术后非感染性结果。进行多变量分析以确定并发症的预测因素。
共有 3293 名患者符合纳入标准。匹配后,有 379 名患者接受了 SingD,379 名患者接受了 SeqD。接受 SingD 与接受 SeqD 的患者之间在术中并发症方面没有显著差异,在圆筒长度方面也没有差异(分别为 20cm,四分位距 [IQR] 18-21cm 与 20cm,IQR 18-20cm,P=0.4)。在多变量分析中,SeqD(OR 5.23,IQR 2.74-10,P<0.001)和年龄较大(OR 1.04,IQR 1.01-1.06,P=0.007)是术后非感染性并发症的预测因素。接受 SingD 与接受 SeqD 的患者之间在术中并发症方面没有显著差异,在圆筒长度方面也没有差异。SeqD 和年龄较大是术后非感染性并发症的预测因素。
在没有纤维化的简单患者中进行可膨胀阴茎假体植入时,SingD 是一种安全的植入技术,可以最大程度地减少术后不良事件,并在不损失圆筒长度的情况下延长器械的使用寿命。